Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for EKTAY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
April 30, 2026 -18.12%
January 31, 2026 0.28%
October 31, 2025 5.63%
July 31, 2025 2.91%
April 30, 2025 -7.39%
January 31, 2025 7.16%
October 31, 2024 4.95%
July 31, 2024 1.86%
April 30, 2024 8.24%
January 31, 2024 6.74%
October 31, 2023 7.27%
July 31, 2023 6.22%
April 30, 2023 10.67%
January 31, 2023 4.98%
October 31, 2022 2.99%
July 31, 2022 1.80%
April 30, 2022 9.93%
January 31, 2022 6.33%
October 31, 2021 10.33%
July 31, 2021 4.19%
April 30, 2021 9.30%
January 31, 2021 8.96%
October 31, 2020 10.61%
July 31, 2020 7.25%
April 30, 2020 10.18%
Date Value
January 31, 2020 8.42%
October 31, 2019 5.96%
July 31, 2019 4.55%
April 30, 2019 13.12%
January 31, 2019 6.39%
October 31, 2018 8.53%
July 31, 2018 5.89%
April 30, 2018 14.73%
January 31, 2018 12.41%
October 31, 2017 10.51%
July 31, 2017 7.95%
April 30, 2017 2.50%
January 31, 2017 1.57%
October 31, 2016 2.26%
July 31, 2016 -3.40%
April 30, 2016 2.16%
January 31, 2016 0.27%
October 31, 2015 6.68%
July 31, 2015 -5.76%
April 30, 2015 8.90%
January 31, 2015 5.96%
October 31, 2014 7.79%
July 31, 2014 -7.35%
April 30, 2014 20.71%
January 31, 2014 6.29%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Surgical Science Sweden AB 7.91%
Senzime AB -96.90%
Redsense Medical AB 17.48%
Acarix AB -362.2%
Accuray, Inc. -11.26%